{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:54:55Z","timestamp":1791431695564,"version":"4.3.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["T32HL007055"],"award-info":[{"award-number":["T32HL007055"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["F32HL149256"],"award-info":[{"award-number":["F32HL149256"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ajpc.2026.101716","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:37:55Z","timestamp":1782319075000},"page":"101716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0881-5063","authenticated-orcid":false,"given":"Moa P.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Alegre\u2011Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Berumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Kuri-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari E.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Til","family":"St\u00fcrmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaelisa","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy L.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101716_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI working group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0002","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2020.5685","article-title":"Lipids and Lipoproteins in 2020","volume":"324","author":"Ference","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101716_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajpc.2026.101716_bib0004","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101716_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2009.12.036","article-title":"Lipoprotein(a) and ischemic heart disease\u2013a causal association? A review","volume":"211","author":"Kamstrup","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2026.101716_bib0006","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101716_bib0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40842-016-0024-x","article-title":"Lipoprotein (a), an independent cardiovascular risk marker","volume":"2","author":"Saeedi","year":"2016","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0008","first-page":"1129","article-title":"2021 canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2019.10.011","article-title":"HEART UK consensus statement on Lipoprotein(a): A call to action","volume":"291","author":"Cegla","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2026.101716_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2026.101716_bib0011","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","article-title":"Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. a scientific statement from the National Lipid Association","volume":"13","author":"Wilson","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0012","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small interfering rna to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101716_bib0013","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.2024.21957","article-title":"Zerlasiran-a small-interfering rna targeting lipoprotein(a): a phase 2 randomized clinical trial","volume":"332","author":"Nissen","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101716_bib0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.2024.24017","article-title":"Oral muvalaplin for lowering of lipoprotein(a): a randomized clinical trial","volume":"333","author":"Nicholls","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101716_bib0015","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2019.10.019","article-title":"Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes","volume":"74","author":"Gudbjartsson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0016","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abg8289","article-title":"Protein-coding repeat polymorphisms strongly shape diverse human phenotypes","volume":"373","author":"Mukamel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ajpc.2026.101716_bib0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2022.04.016","article-title":"Lipoprotein (a)and diabetes mellitus","volume":"349","author":"Lamina","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2026.101716_bib0018","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/clinchem.2010.146779","article-title":"Lipoprotein(a) and risk of type 2 diabetes","volume":"56","author":"Mora","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpc.2026.101716_bib0019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12933-017-0520-z","article-title":"Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature","volume":"16","author":"Paige","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0020","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehaa1085","article-title":"Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study","volume":"42","author":"Langsted","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2026.101716_bib0021","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/8.11.2087","article-title":"Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians","volume":"8","author":"Ogorelkova","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpc.2026.101716_bib0022","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fpubh.2017.00329","article-title":"The genetic basis of type 2 diabetes in hispanics and latin americans: challenges and opportunities","volume":"5","author":"Mercader","year":"2017","journal-title":"Front Public Health"},{"key":"10.1016\/j.ajpc.2026.101716_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000765","article-title":"Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study","volume":"7","author":"Muilwijk","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.ajpc.2026.101716_bib0024","first-page":"A53","article-title":"Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007","volume":"7","author":"Fisher-Hoch","year":"2010","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.ajpc.2026.101716_bib0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.annepidem.2010.03.015","article-title":"Design and implementation of the hispanic community health study\/study of latinos","volume":"20","author":"Sorlie","year":"2010","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0026","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ije\/dyl042","article-title":"Cohort profile: the Mexico City Prospective Study","volume":"35","author":"Tapia-Conyer","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ajpc.2026.101716_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajpc.2026.101716_bib0029","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1038\/ncomms9111","article-title":"Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel","volume":"6","author":"Huang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpc.2026.101716_bib0030","series-title":"Genotyping, sequencing and analysis of 140,000 adults from the Mexico City Prospective Study","author":"Ziyatdinov","year":"2022"},{"key":"10.1016\/j.ajpc.2026.101716_bib0031","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2012.14517","article-title":"Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic\/Latino individuals of diverse backgrounds in the United States","volume":"308","author":"Daviglus","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101716_bib0032","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ajhg.2014.11.005","article-title":"Genetic association analysis under complex survey sampling: the hispanic community health study\/study of latinos","volume":"95","author":"Lin","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpc.2026.101716_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001867","article-title":"High cholesterol awareness, treatment, and control among hispanic\/latinos: results from the hispanic community health study\/study of latinos","volume":"4","author":"Rodriguez","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2026.101716_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167758","article-title":"Strategies for enriching variant coverage in candidate disease loci on a multiethnic genotyping array","volume":"11","author":"Bien","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2026.101716_bib0035","article-title":"Missed opportunities for diagnosis and treatment of diabetes, hypertension, and hypercholesterolemia in a Mexican American population, Cameron County Hispanic Cohort, 2003-2008","volume":"9","author":"Fisher-Hoch","year":"2012","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.ajpc.2026.101716_bib0036","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12933-023-01968-4","article-title":"Sex-specific associations between adipokine profiles and carotid-intima media thickness in the cameron county hispanic cohort (CCHC)","volume":"22","author":"Kim","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0037","doi-asserted-by":"crossref","first-page":"222","DOI":"10.12688\/wellcomeopenres.16171.1","article-title":"Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank","volume":"5","author":"Allen","year":"2020","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ajpc.2026.101716_bib0038","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s43856-022-00208-2","article-title":"Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults","volume":"2","author":"Aguilar-Ramirez","year":"2022","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.ajpc.2026.101716_bib0039","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/clinchem\/48.9.1627","article-title":"Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies","volume":"48","author":"Youngman","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpc.2026.101716_bib0040","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/biomedicines12071493","article-title":"The Triglyceride\/HDL Ratio as a Surrogate Biomarker for Insulin Resistance","volume":"12","author":"Baneu","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpc.2026.101716_bib0041","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diabres.2019.01.030","article-title":"Associations of insulin resistance with cognition in individuals without diagnosed diabetes: results from the hispanic community health study\/study of latinos","volume":"150","author":"Gonzales","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajpc.2026.101716_bib0042","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","article-title":"Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpc.2026.101716_bib0043","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.ajpc.2026.101716_bib0044","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S2213-8587(13)70064-0","article-title":"Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study","volume":"1","author":"Kamstrup","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311427","article-title":"Diabetes mellitus and lipoprotein(a): a determinant interaction in micro- and macrovascular damage","volume":"26","author":"Polo-Barranco","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2026.101716_bib0046","article-title":"Relationship between metabolic dysfunction-associated steatotic liver disease and lipoprotein(a) and other biomarkers","volume":"16","author":"Munoz Rossi","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ajpc.2026.101716_bib0047","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1055\/s-0043-1771188","article-title":"Inverse association of lipoprotein(a) on long-term bleeding risk in patients with coronary heart disease: insight from a multicenter cohort in Asia","volume":"124","author":"Wang","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajpc.2026.101716_bib0048","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc20-2842","article-title":"Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment","volume":"44","author":"Schwartz","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101716_bib0049","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MOL.0000000000000735","article-title":"Editorial comment: when Mendelian randomization goes astray","volume":"32","author":"Hegele","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101716_bib0051","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101716_bib0052","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","article-title":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","volume":"5","author":"Schmidt","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101716_bib0053","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1074248420924983","article-title":"Proprotein convertase subtilisin\/kexin type 9 inhibitors and ezetimibe on risk of new-onset diabetes: a systematic review and meta-analysis of large, double-blinded randomized controlled trials","volume":"25","author":"Chiu","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ajpc.2026.101716_bib0054","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101716_bib0055","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040980","article-title":"Using mendelian randomization to improve the design of randomized trials","volume":"11","author":"Ference","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ajpc.2026.101716_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004494","article-title":"Distribution and medical impact of loss-of-function variants in the Finnish founder population","volume":"10","author":"Lim","year":"2014","journal-title":"PLoS Genet"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:38:24Z","timestamp":1791430704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":56,"alternative-id":["S2666667726002916"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101716","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101716"}}